1. Market Research
  2. > Pharmaceutical Market Trends
  3. > United States Active Pharmaceutical Ingredients (API) Industry Report 2015

Summary


The United States Active Pharmaceutical Ingredients (API) Industry Report 2015 is a professional and in-depth study on the current state of the Active Pharmaceutical Ingredients (API) industry.

The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Active Pharmaceutical Ingredients (API) market analysis is provided for the United States markets including development trends, competitive landscape analysis, and key regions development status.

Development policies and plans are discussed as well as manufacturing processes and Bill of Materials cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins.

The report focuses on United States major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The Active Pharmaceutical Ingredients (API) industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered.

With 239 tables and figures the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

Table Of Contents

United States Active Pharmaceutical Ingredients (API) Industry Report 2015
Table of Contents

Chapter One Industry Overview
1.1 Definition and Specifications of Active Pharmaceutical Ingredients (API)
1.2 Classification of Active Pharmaceutical Ingredients (API)
1.3 Applications of Active Pharmaceutical Ingredients (API)
1.4 Industry Chain Structure of Active Pharmaceutical Ingredients (API)
1.5 Industry Overview of Active Pharmaceutical Ingredients (API)
1.6 Industry Policy Analysis of Active Pharmaceutical Ingredients (API)
1.7 Industry News Analysis of Active Pharmaceutical Ingredients (API)

Chapter Two Manufacturing Cost Structure Analysis of Active Pharmaceutical Ingredients (API)
2.1 Bill of Materials (BOM) of Active Pharmaceutical Ingredients (API)
2.2 BOM Price Analysis of Active Pharmaceutical Ingredients (API)
2.3 Labor Cost Analysis of Active Pharmaceutical Ingredients (API)
2.4 Depreciation Cost Analysis of Active Pharmaceutical Ingredients (API)
2.5 Manufacturing Cost Structure Analysis of Active Pharmaceutical Ingredients (API)
2.6 Manufacturing Process Analysis of Active Pharmaceutical Ingredients (API)

Chapter Three Technical Data and Manufacturing Plants Analysis
3.1 Capacity and Commercial Production Date of United States Key Manufacturers in 2014
3.2 Manufacturing Plants Distribution of United States Key Active Pharmaceutical Ingredients (API) Manufacturers in 2014
3.3 RandD Status and Technology Source of United States Active Pharmaceutical Ingredients (API) Key Manufacturers in 2014
3.4 Raw Materials Sources Analysis of United States Active Pharmaceutical Ingredients (API) Key Manufacturers in 2014

Chapter Four Production Analysis of Active Pharmaceutical Ingredients (API) by Regions, Technology, and Applications
4.1 United States Production of Active Pharmaceutical Ingredients (API) by Regions (Key Provinces) 2010-2015
4.2 United States Production of Active Pharmaceutical Ingredients (API) by Product Types 2010-2015
4.3 United States Sales of Active Pharmaceutical Ingredients (API) by Applications 2010-2015
4.4 Price Analysis of United States Active Pharmaceutical Ingredients (API) Key Manufacturers in 2015
4.5 United States Capacity, Production, Import, Export, Sales, Price, Cost and Revenue of Active Pharmaceutical Ingredients (API) 2010-2015

Chapter Five Sales and Revenue Analysis of Active Pharmaceutical Ingredients (API) by Regions
5.1 United States Sales of Active Pharmaceutical Ingredients (API) by Regions 2010-2015
5.2 United States Revenue of Active Pharmaceutical Ingredients (API) by Regions 2010-2015
5.3 United States Price Analysis of Active Pharmaceutical Ingredients (API) Sales by Regions 2010-2015
5.4 United States Price, Cost and Gross of Active Pharmaceutical Ingredients (API) 2010-2015

Chapter Six Analysis of Active Pharmaceutical Ingredients (API) Production, Supply, Sales and Market Status 2010-2015
6.1 Capacity Production Sales Revenue of Active Pharmaceutical Ingredients (API) 2010-2015
6.2 Production Sales Market Share Analysis of Active Pharmaceutical Ingredients (API) 2014-2015
6.3 Import, Export and Consumption of Active Pharmaceutical Ingredients (API) 2010-2015
6.4 Supply, Consumption and Shortage of Active Pharmaceutical Ingredients (API) 2010-2015
6.5 Import, Export and Consumption of Active Pharmaceutical Ingredients (API) 2010-2015
6.6 Cost, Price, Revenue and Gross Margin of Active Pharmaceutical Ingredients (API) 2010-2015

Chapter Seven Analysis of Active Pharmaceutical Ingredients (API) Industry Key Manufacturers
7.1 Mylan
7.1.1 Company Profile
7.1.2 Product Picture and Specification
7.1.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.1.4 Mylan SWOT Analysis

7.2 Abbott Laboratories
7.2.1 Company Profile
7.2.2 Product Picture and Specification
7.2.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.2.4 Abbott Laboratories SWOT Analysis

7.3 Teva Pharmaceutical Industries
7.3.1 Company Profile
7.3.2 Product Picture and Specification
7.3.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.3.4 Teva Pharmaceutical Industries SWOT Analysis

7.4 Aurobindo Pharma
7.4.1 Company Profile
7.4.2 Product Picture and Specification
7.4.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.4.4 Aurobindo Pharma SWOT Analysis

7.5 Novartis
7.5.1 Company Profile
7.5.2 Product Picture and Specification
7.5.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.5.4 Novartis SWOT Analysis

7.6 Pfizer
7.6.1 Company Profile
7.6.2 Product Picture and Specification
7.6.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.6.4 Pfizer SWOT Analysis

7.7 Sigma-Aldrich
7.7.1 Company Profile
7.7.2 Product Picture and Specification
7.7.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.7.4 Sigma-Aldrich SWOT Analysis

7.8 Sun Pharmaceutical Industries
7.8.1 Company Profile
7.8.2 Product Picture and Specification
7.8.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.8.4 Sun Pharmaceutical Industries SWOT Analysis

7.9 Dr. Reddy's Laboratories
7.9.1 Company Profile
7.9.2 Product Picture and Specification
7.9.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.9.4 Dr. Reddy's Laboratories SWOT Analysis

7.10 Hospira
7.10.1 Company Profile
7.10.2 Product Picture and Specification
7.10.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.10.4 Hospira SWOT Analysis

7.11 Lonza Group
7.11.1 Company Profile
7.11.2 Product Picture and Specification
7.11.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.11.4 Lonza Group SWOT Analysis

7.12 BASF
7.12.1 Company Profile
7.12.2 Product Picture and Specification
7.12.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.12.4 BASF SWOT Analysis

7.13 Biocon
7.13.1 Company Profile
7.13.2 Product Picture and Specification
7.13.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.13.4 Biocon SWOT Analysis

7.14 Boehringer Ingelheim
7.14.1 Company Profile
7.14.2 Product Picture and Specification
7.14.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.14.4 Boehringer Ingelheim SWOT Analysis

7.15 Cambrex
7.15.1 Company Profile
7.15.2 Product Picture and Specification
7.15.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.15.4 Cambrex SWOT Analysis

7.16 Cipla
7.16.1 Company Profile
7.16.2 Product Picture and Specification
7.16.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.16.4 Cipla SWOT Analysis

7.17 Albemarle
7.17.1 Company Profile
7.17.2 Product Picture and Specification
7.17.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.17.4 Albemarle SWOT Analysis

7.18 Aptuit
7.18.1 Company Profile
7.18.2 Product Picture and Specification
7.18.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.18.4 Aptuit SWOT Analysis

Chapter Eight Price and Gross Margin Analysis
8.1 Analysis of Price
8.2 Gross Margin Analysis
8.3 Price Comparison by Regions
8.4 Price Analysis of Different Active Pharmaceutical Ingredients (API) Product Types
8.5 Market Share Analysis of Different Active Pharmaceutical Ingredients (API) Price Levels
8.6 Gross Margin Analysis of Different Active Pharmaceutical Ingredients (API) Applications

Chapter Nine Marketing Trader or Distributor Analysis of Active Pharmaceutical Ingredients (API)
9.1 Marketing Channels Status of Active Pharmaceutical Ingredients (API)
9.2 Traders or Distributors of Active Pharmaceutical Ingredients (API) with Contact Information
9.3 Ex-work Price, Channel Price and End Buyer Price Analysis of Active Pharmaceutical Ingredients (API)
9.4 United States Import, Export and Trade Analysis of Active Pharmaceutical Ingredients (API)

Chapter Ten Development Trend of Active Pharmaceutical Ingredients (API) Industry 2015-2020
10.1 Capacity and Production Overview of Active Pharmaceutical Ingredients (API) 2015-2020
10.2 Production Market Share by Product Types of Active Pharmaceutical Ingredients (API) 2015-2020
10.3 Sales and Sales Revenue Overview of Active Pharmaceutical Ingredients (API) 2015-2020
10.4 United States Sales of Active Pharmaceutical Ingredients (API) by Applications 2015-2020
10.5 Import, Export and Consumption of Active Pharmaceutical Ingredients (API) 2015-2020
10.6 Cost, Price, Revenue and Gross Margin of Active Pharmaceutical Ingredients (API) 2015-2020

Chapter Eleven Industry Chain Suppliers of Active Pharmaceutical Ingredients (API) with Contact Information
11.1 Major Raw Materials Suppliers of Active Pharmaceutical Ingredients (API) with Contact Information
11.2 Manufacturing Equipment Suppliers of Active Pharmaceutical Ingredients (API) with Contact Information
11.3 Major Players of Active Pharmaceutical Ingredients (API) with Contact Information
11.4 Key Consumers of Active Pharmaceutical Ingredients (API) with Contact Information
11.5 Supply Chain Relationship Analysis of Active Pharmaceutical Ingredients (API)

Chapter Twelve New Project Investment Feasibility Analysis of Active Pharmaceutical Ingredients (API)
12.1 New Project SWOT Analysis of Active Pharmaceutical Ingredients (API)
12.2 New Project Investment Feasibility Analysis of Active Pharmaceutical Ingredients (API)

Chapter Thirteen Conclusion of the United States Active Pharmaceutical Ingredients (API) Industry Report 2015




List of Tables and Figures

Figure Picture of Active Pharmaceutical Ingredients (API)
Table Product Specifications of Active Pharmaceutical Ingredients (API)
Table Classification of Active Pharmaceutical Ingredients (API)
Figure United States Sales Market Share of Active Pharmaceutical Ingredients (API) by Product Types in 2014
Table Applications of Active Pharmaceutical Ingredients (API)
Figure United States Sales Market Share of Active Pharmaceutical Ingredients (API) by Applications in 2014
Figure Industry Chain Structure of Active Pharmaceutical Ingredients (API)
Table United States Industry Overview of Active Pharmaceutical Ingredients (API)
Table Industry Policy of Active Pharmaceutical Ingredients (API)
Table Industry News List of Active Pharmaceutical Ingredients (API)
Table Bill of Materials (BOM) of Active Pharmaceutical Ingredients (API)
Table Bill of Materials (BOM) Price of Active Pharmaceutical Ingredients (API)
Table Labor Cost of Active Pharmaceutical Ingredients (API)
Table Depreciation Cost of Active Pharmaceutical Ingredients (API)
Table Manufacturing Cost Structure Analysis of Active Pharmaceutical Ingredients (API) in 2014
Figure Manufacturing Process Analysis of Active Pharmaceutical Ingredients (API)
Table Capacity (K MT) and Commercial Production Date of United States Active Pharmaceutical Ingredients (API) Key Manufacturers in 2014
Table Manufacturing Plants Distribution of United States Key Active Pharmaceutical Ingredients (API) Manufacturers in 2014
Table RandD Status and Technology Source of United States Active Pharmaceutical Ingredients (API) Key Manufacturers in 2014
Table Raw Materials Sources Analysis of United States and United States Active Pharmaceutical Ingredients (API) Key Manufacturers in 2014
Table United States Production of Active Pharmaceutical Ingredients (API) by Regions 2010-2015 (K MT)
Table United States Production Market Share of Active Pharmaceutical Ingredients (API) by Regions 2010-2015 (%)
Figure United States Production Market Share of Active Pharmaceutical Ingredients (API) by Regions in 2014
Figure United States Production Market Share of Active Pharmaceutical Ingredients (API) by Regions in 2015
Table United States Production of Active Pharmaceutical Ingredients (API) by Product Types in 2010-2015 (K MT)
Table United States Production Market Share of Active Pharmaceutical Ingredients (API) by Product Types in 2010-2015 (%)
Figure United States Production Market Share of Active Pharmaceutical Ingredients (API) by Technology in 2014
Figure United States Production Market Share of Active Pharmaceutical Ingredients (API) by Technology in 2015
Figure United States Sales of Active Pharmaceutical Ingredients (API) by Applications 2010-2015 (K MT)
Table United States Production Market Share of Active Pharmaceutical Ingredients (API) by Applications 2010-2015 (%)
Figure United States Production Market Share of Active Pharmaceutical Ingredients (API) by Applications in 2014
Figure United States Production Market Share of Active Pharmaceutical Ingredients (API) by Applications in 2015
Table Price Comparison of United States Active Pharmaceutical Ingredients (API) Key Manufacturers in 2015 (USD/MT)
Table United States Capacity, Production, Import Export Sales Price , Cost and Revenue (M USD) of Active Pharmaceutical Ingredients (API) 2010-2015
Table United States Sales of Active Pharmaceutical Ingredients (API) by Regions 2010-2015 (K MT)
Table United States Sales Market Share of Active Pharmaceutical Ingredients (API) by Regions 2010-2015 (%)
Figure United States Sales of Active Pharmaceutical Ingredients (API) by Regions in 2014 (K MT)
Figure United States Sales of Active Pharmaceutical Ingredients (API) by Regions in 2015 (K MT)
Table United States Revenue of Active Pharmaceutical Ingredients (API) by Regions 2010-2015 (M USD)
Table United States Revenue of Active Pharmaceutical Ingredients (API) by Regions 2010-2015 (%)
Figure United States Revenue of Active Pharmaceutical Ingredients (API) by Regions in 2014 (%)
Figure United States Revenue of Active Pharmaceutical Ingredients (API) by Regions in 2015 (%)
Table Sales Price of Active Pharmaceutical Ingredients (API) by Regions 2010-2015 (USD/MT)
Table United States Price Analysis of Active Pharmaceutical Ingredients (API) 2010-2015 (USD/MT)
Table United States Cost Analysis of Active Pharmaceutical Ingredients (API) 2010-2015 (USD/MT)
Table United States Gross Analysis of Active Pharmaceutical Ingredients (API) 2010-2015
Table United States and Major Manufacturers Capacity of Active Pharmaceutical Ingredients (API) 2010-2015 (K MT)
Table United States Capacity Market Share of Major Active Pharmaceutical Ingredients (API) Manufacturers 2010-2015 (%)
Table United States and Major Manufacturers Production of Active Pharmaceutical Ingredients (API) 2010-2015 (K MT)
Table United States Production Market Share of Major Active Pharmaceutical Ingredients (API) Manufacturers 2010-2015 (%)
Table United States and Major Manufacturers Sales of Active Pharmaceutical Ingredients (API) 2010-2015 (K MT)
Table United States Sales Market Share of Major Active Pharmaceutical Ingredients (API) Manufacturers 2010-2015 (%)
Table United States and Major Manufacturers Sales Revenue of Active Pharmaceutical Ingredients (API) 2010-2015 (M USD)
Table United States Sales Revenue Market Share of Major Active Pharmaceutical Ingredients (API) Manufacturers 2010-2015 (%)
Figure United States Capacity (K MT), Production (K MT) and Growth Rate of Active Pharmaceutical Ingredients (API) 2010-2015
Figure United States Capacity Utilization Rate of Active Pharmaceutical Ingredients (API) 2010-2015
Figure United States Sales Revenue (M USD) and Growth Rate of Active Pharmaceutical Ingredients (API) 2010-2015
Figure United States Production Market Share of Major Active Pharmaceutical Ingredients (API) Manufacturers in 2014
Figure United States Production Market Share of Major Active Pharmaceutical Ingredients (API) Manufacturers in 2015
Figure United States Sales Market Share of Major Active Pharmaceutical Ingredients (API) Manufacturers in 2014
Figure United States Sales Market Share of Major Active Pharmaceutical Ingredients (API) Manufacturers in 2015
Table United States Import, Export and Consumption of Active Pharmaceutical Ingredients (API) 2010-2015 (K MT)
Table United States and Major Manufacturers Local Sales Export Import of Active Pharmaceutical Ingredients (API) 2010-2015 (K MT)
Table United States Supply, Consumption and Shortage of Active Pharmaceutical Ingredients (API) 2010-2015 (K MT)
Table United States Import, Export and Consumption of Active Pharmaceutical Ingredients (API) 2010-2015 (K MT)
Table Price of United States Active Pharmaceutical Ingredients (API) Major Manufacturers 2010-2015 (USD/MT)
Table Gross Margin of United States Active Pharmaceutical Ingredients (API) Major Manufacturers 2010-2015
Table United States and Major Manufacturers Revenue of Active Pharmaceutical Ingredients (API) 2010-2015 (M USD)
Table United States Production (K MT), Price (USD/MT), Cost (USD/MT), Revenue (M USD) and Gross Margin of Active Pharmaceutical Ingredients (API) 2010-2015
Table Mylan Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Active Pharmaceutical Ingredients (API) Picture and Specifications of Mylan
Table Active Pharmaceutical Ingredients (API) Capacity (K MT), Production (K MT), Price (USD/MT), Cost (USD/MT), Gross (USD/MT), Revenue (M USD) and Gross Margin of Mylan 2010-2015
Figure Active Pharmaceutical Ingredients (API) Capacity (K MT), Production (K MT) and Growth Rate of Mylan 2010-2015
Figure Active Pharmaceutical Ingredients (API) Production (K MT) and United States Market Share of Mylan 2010-2015
Table Mylan Active Pharmaceutical Ingredients (API) SWOT Analysis
Table Abbott Laboratories Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Active Pharmaceutical Ingredients (API) Picture and Specifications of Abbott Laboratories
Table Active Pharmaceutical Ingredients (API) Capacity (K MT), Production (K MT), Price (USD/MT), Cost (USD/MT), Gross (USD/MT), Revenue (M USD) and Gross Margin of Abbott Laboratories 2010-2015
Figure Active Pharmaceutical Ingredients (API) Capacity (K MT), Production (K MT) and Growth Rate of Abbott Laboratories 2010-2015
Figure Active Pharmaceutical Ingredients (API) Production (K MT) and United States Market Share of Abbott Laboratories 2010-2015
Table Abbott Laboratories Active Pharmaceutical Ingredients (API) SWOT Analysis
Table Teva Pharmaceutical Industries Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Active Pharmaceutical Ingredients (API) Picture and Specifications of Teva Pharmaceutical Industries
Table Active Pharmaceutical Ingredients (API) Capacity (K MT), Production (K MT), Price (USD/MT), Cost (USD/MT), Gross (USD/MT), Revenue (M USD) and Gross Margin of Teva Pharmaceutical Industries 2010-2015
Figure Active Pharmaceutical Ingredients (API) Capacity (K MT), Production (K MT) and Growth Rate of Teva Pharmaceutical Industries 2010-2015
Figure Active Pharmaceutical Ingredients (API) Production (K MT) and United States Market Share of Teva Pharmaceutical Industries 2010-2015
Table Teva Pharmaceutical Industries Active Pharmaceutical Ingredients (API) SWOT Analysis
Table Aurobindo Pharma Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Active Pharmaceutical Ingredients (API) Picture and Specifications of Aurobindo Pharma
Table Active Pharmaceutical Ingredients (API) Capacity (K MT), Production (K MT), Price (USD/MT), Cost (USD/MT), Gross (USD/MT), Revenue (M USD) and Gross Margin of Aurobindo Pharma 2010-2015
Figure Active Pharmaceutical Ingredients (API) Capacity (K MT), Production (K MT) and Growth Rate of Aurobindo Pharma 2010-2015
Figure Active Pharmaceutical Ingredients (API) Production (K MT) and United States Market Share of Aurobindo Pharma 2010-2015
Table Aurobindo Pharma Active Pharmaceutical Ingredients (API) SWOT Analysis
Table Novartis Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Active Pharmaceutical Ingredients (API) Picture and Specifications of Novartis
Table Active Pharmaceutical Ingredients (API) Capacity (K MT), Production (K MT), Price (USD/MT), Cost (USD/MT), Gross (USD/MT), Revenue (M USD) and Gross Margin of Novartis 2010-2015
Figure Active Pharmaceutical Ingredients (API) Capacity (K MT), Production (K MT) and Growth Rate of Novartis 2010-2015
Figure Active Pharmaceutical Ingredients (API) Production (K MT) and United States Market Share of Novartis 2010-2015
Table Novartis Active Pharmaceutical Ingredients (API) SWOT Analysis
Table Pfizer Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Active Pharmaceutical Ingredients (API) Picture and Specifications of Pfizer
Table Active Pharmaceutical Ingredients (API) Capacity (K MT), Production (K MT), Price (USD/MT), Cost (USD/MT), Gross (USD/MT), Revenue (M USD) and Gross Margin of Pfizer 2010-2015
Figure Active Pharmaceutical Ingredients (API) Capacity (K MT), Production (K MT) and Growth Rate of Pfizer 2010-2015
Figure Active Pharmaceutical Ingredients (API) Production (K MT) and United States Market Share of Pfizer 2010-2015
Table Pfizer Active Pharmaceutical Ingredients (API) SWOT Analysis
Table Sigma-Aldrich Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Active Pharmaceutical Ingredients (API) Picture and Specifications of Sigma-Aldrich
Table Active Pharmaceutical Ingredients (API) Capacity (K MT), Production (K MT), Price (USD/MT), Cost (USD/MT), Gross (USD/MT), Revenue (M USD) and Gross Margin of Sigma-Aldrich 2010-2015
Figure Active Pharmaceutical Ingredients (API) Capacity (K MT), Production (K MT) and Growth Rate of Sigma-Aldrich 2010-2015
Figure Active Pharmaceutical Ingredients (API) Production (K MT) and United States Market Share of Sigma-Aldrich 2010-2015
Table Sigma-Aldrich Active Pharmaceutical Ingredients (API) SWOT Analysis
Table Sun Pharmaceutical Industries Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Active Pharmaceutical Ingredients (API) Picture and Specifications of Sun Pharmaceutical Industries
Table Active Pharmaceutical Ingredients (API) Capacity (K MT), Production (K MT), Price (USD/MT), Cost (USD/MT), Gross (USD/MT), Revenue (M USD) and Gross Margin of Sun Pharmaceutical Industries 2010-2015
Figure Active Pharmaceutical Ingredients (API) Capacity (K MT), Production (K MT) and Growth Rate of Sun Pharmaceutical Industries 2010-2015
Figure Active Pharmaceutical Ingredients (API) Production (K MT) and United States Market Share of Sun Pharmaceutical Industries 2010-2015
Table Sun Pharmaceutical Industries Active Pharmaceutical Ingredients (API) SWOT Analysis
Table Dr. Reddy's Laboratories Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Active Pharmaceutical Ingredients (API) Picture and Specifications of Dr. Reddy's Laboratories
Table Active Pharmaceutical Ingredients (API) Capacity (K MT), Production (K MT), Price (USD/MT), Cost (USD/MT), Gross (USD/MT), Revenue (M USD) and Gross Margin of Dr. Reddy's Laboratories 2010-2015
Figure Active Pharmaceutical Ingredients (API) Capacity (K MT), Production (K MT) and Growth Rate of Dr. Reddy's Laboratories 2010-2015
Figure Active Pharmaceutical Ingredients (API) Production (K MT) and United States Market Share of Dr. Reddy's Laboratories 2010-2015
Table Dr. Reddy's Laboratories Active Pharmaceutical Ingredients (API) SWOT Analysis
Table Hospira Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Active Pharmaceutical Ingredients (API) Picture and Specifications of Hospira
Table Active Pharmaceutical Ingredients (API) Capacity (K MT), Production (K MT), Price (USD/MT), Cost (USD/MT), Gross (USD/MT), Revenue (M USD) and Gross Margin of Hospira 2010-2015
Figure Active Pharmaceutical Ingredients (API) Capacity (K MT), Production (K MT) and Growth Rate of Hospira 2010-2015
Figure Active Pharmaceutical Ingredients (API) Production (K MT) and United States Market Share of Hospira 2010-2015
Table Hospira Active Pharmaceutical Ingredients (API) SWOT Analysis
Table Lonza Group Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Active Pharmaceutical Ingredients (API) Picture and Specifications of Lonza Group
Table Active Pharmaceutical Ingredients (API) Capacity (K MT), Production (K MT), Price (USD/MT), Cost (USD/MT), Gross (USD/MT), Revenue (M USD) and Gross Margin of Lonza Group 2010-2015
Figure Active Pharmaceutical Ingredients (API) Capacity (K MT), Production (K MT) and Growth Rate of Lonza Group 2010-2015
Figure Active Pharmaceutical Ingredients (API) Production (K MT) and United States Market Share of Lonza Group 2010-2015
Table Lonza Group Active Pharmaceutical Ingredients (API) SWOT Analysis
Table BASF Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Active Pharmaceutical Ingredients (API) Picture and Specifications of BASF
Table Active Pharmaceutical Ingredients (API) Capacity (K MT), Production (K MT), Price (USD/MT), Cost (USD/MT), Gross (USD/MT), Revenue (M USD) and Gross Margin of BASF 2010-2015
Figure Active Pharmaceutical Ingredients (API) Capacity (K MT), Production (K MT) and Growth Rate of BASF 2010-2015
Figure Active Pharmaceutical Ingredients (API) Production (K MT) and United States Market Share of BASF 2010-2015
Table BASF Active Pharmaceutical Ingredients (API) SWOT Analysis
Table Biocon Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Active Pharmaceutical Ingredients (API) Picture and Specifications of Biocon
Table Active Pharmaceutical Ingredients (API) Capacity (K MT), Production (K MT), Price (USD/MT), Cost (USD/MT), Gross (USD/MT), Revenue (M USD) and Gross Margin of Biocon 2010-2015
Figure Active Pharmaceutical Ingredients (API) Capacity (K MT), Production (K MT) and Growth Rate of Biocon 2010-2015
Figure Active Pharmaceutical Ingredients (API) Production (K MT) and United States Market Share of Biocon 2010-2015
Table Biocon Active Pharmaceutical Ingredients (API) SWOT Analysis
Table Boehringer Ingelheim Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Active Pharmaceutical Ingredients (API) Picture and Specifications of Boehringer Ingelheim
Table Active Pharmaceutical Ingredients (API) Capacity (K MT), Production (K MT), Price (USD/MT), Cost (USD/MT), Gross (USD/MT), Revenue (M USD) and Gross Margin of Boehringer Ingelheim 2010-2015
Figure Active Pharmaceutical Ingredients (API) Capacity (K MT), Production (K MT) and Growth Rate of Boehringer Ingelheim 2010-2015
Figure Active Pharmaceutical Ingredients (API) Production (K MT) and United States Market Share of Boehringer Ingelheim 2010-2015
Table Boehringer Ingelheim Active Pharmaceutical Ingredients (API) SWOT Analysis
Table Cambrex Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Active Pharmaceutical Ingredients (API) Picture and Specifications of Cambrex
Table Active Pharmaceutical Ingredients (API) Capacity (K MT), Production (K MT), Price (USD/MT), Cost (USD/MT), Gross (USD/MT), Revenue (M USD) and Gross Margin of Cambrex 2010-2015
Figure Active Pharmaceutical Ingredients (API) Capacity (K MT), Production (K MT) and Growth Rate of Cambrex 2010-2015
Figure Active Pharmaceutical Ingredients (API) Production (K MT) and United States Market Share of Cambrex 2010-2015
Table Cambrex Active Pharmaceutical Ingredients (API) SWOT Analysis
Table Cipla Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Active Pharmaceutical Ingredients (API) Picture and Specifications of Cipla
Table Active Pharmaceutical Ingredients (API) Capacity (K MT), Production (K MT), Price (USD/MT), Cost (USD/MT), Gross (USD/MT), Revenue (M USD) and Gross Margin of Cipla 2010-2015
Figure Active Pharmaceutical Ingredients (API) Capacity (K MT), Production (K MT) and Growth Rate of Cipla 2010-2015
Figure Active Pharmaceutical Ingredients (API) Production (K MT) and United States Market Share of Cipla 2010-2015
Table Cipla Active Pharmaceutical Ingredients (API) SWOT Analysis
Table Albemarle Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Active Pharmaceutical Ingredients (API) Picture and Specifications of Albemarle
Table Active Pharmaceutical Ingredients (API) Capacity (K MT), Production (K MT), Price (USD/MT), Cost (USD/MT), Gross (USD/MT), Revenue (M USD) and Gross Margin of Albemarle 2010-2015
Figure Active Pharmaceutical Ingredients (API) Capacity (K MT), Production (K MT) and Growth Rate of Albemarle 2010-2015
Figure Active Pharmaceutical Ingredients (API) Production (K MT) and United States Market Share of Albemarle 2010-2015
Table Albemarle Active Pharmaceutical Ingredients (API) SWOT Analysis
Table Aptuit Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Active Pharmaceutical Ingredients (API) Picture and Specifications of Aptuit
Table Active Pharmaceutical Ingredients (API) Capacity (K MT), Production (K MT), Price (USD/MT), Cost (USD/MT), Gross (USD/MT), Revenue (M USD) and Gross Margin of Aptuit 2010-2015
Figure Active Pharmaceutical Ingredients (API) Capacity (K MT), Production (K MT) and Growth Rate of Aptuit 2010-2015
Figure Active Pharmaceutical Ingredients (API) Production (K MT) and United States Market Share of Aptuit 2010-2015
Table Aptuit Active Pharmaceutical Ingredients (API) SWOT Analysis
Table Active Pharmaceutical Ingredients (API) Price by Regions 2010-2015
Table Active Pharmaceutical Ingredients (API) Price by Product Types 2010-2015
Table Active Pharmaceutical Ingredients (API) Price by Company 2010-2015
Table Active Pharmaceutical Ingredients (API) Gross Margin by Company 2010-2015
Table Price Comparison of Active Pharmaceutical Ingredients (API) by Regions 2010-2015 (USD/MT)
Table Price of Different Active Pharmaceutical Ingredients (API) Product Types (USD/MT)
Table Market Share of Different Active Pharmaceutical Ingredients (API) Price Level
Table Gross Margin of Different Active Pharmaceutical Ingredients (API) Applications
Table Marketing Channels Status of Active Pharmaceutical Ingredients (API)
Table Traders or Distributors of Active Pharmaceutical Ingredients (API) with Contact Information
Table Ex-work Price, Channel Price and End Buyer Price of Active Pharmaceutical Ingredients (API) (USD/MT)
Table United States Import, Export, and Trade of Active Pharmaceutical Ingredients (API) (K MT)
Figure United States Capacity (K MT), Production (K MT) and Growth Rate of Active Pharmaceutical Ingredients (API) 2015-2020
Figure United States Capacity Utilization Rate of Active Pharmaceutical Ingredients (API) 2015-2020
Table United States Active Pharmaceutical Ingredients (API) Production by Product Types 2010-2015 (K MT)
Table United States Active Pharmaceutical Ingredients (API) Production Market Share by Product Types 2010-2015 (%)
Figure United States Production Market Share of Active Pharmaceutical Ingredients (API) by Technology in 2020
Figure United States Sales (K MT) and Growth Rate of Active Pharmaceutical Ingredients (API) 2015-2020
Figure United States Sales Revenue (Million USD) and Growth Rate of Active Pharmaceutical Ingredients (API) 2015-2020
Figure United States Sales of Active Pharmaceutical Ingredients (API) by Applications 2015-2020 (K MT)
Table United States Production Market Share of Active Pharmaceutical Ingredients (API) by Applications 2015-2020 (%)
Figure United States Production Market Share of Active Pharmaceutical Ingredients (API) by Applications in 2020
Table United States Production, Import, Export and Consumption of Active Pharmaceutical Ingredients (API) 2015-2020 (K MT)
Table United States Production (K MT), Price (USD/MT), Cost (USD/MT), Revenue (M USD) and Gross Margin of Active Pharmaceutical Ingredients (API) 2015-2020
Table Major Raw Materials Suppliers of Active Pharmaceutical Ingredients (API) with Contact Information
Table Manufacturing Equipment Suppliers of Active Pharmaceutical Ingredients (API) with Contact Information
Table Major Players of Active Pharmaceutical Ingredients (API) with Contact Information
Table Key Consumers of Active Pharmaceutical Ingredients (API) with Contact Information
Table Supply Chain Relationship Analysis of Active Pharmaceutical Ingredients (API)
Table New Project SWOT Analysis of Active Pharmaceutical Ingredients (API)
Table New Project Investment Feasibility Analysis of Active Pharmaceutical Ingredients (API)
Table Part of Interviewees Record List

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Atrial Fibrillation - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Atrial Fibrillation - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • August 2016
  • by Global Data

PharmaPoint: Atrial Fibrillation - Global Drug Forecast and Market Analysis to 2025 Summary Atrial fibrillation (AF) is the most common cardiac arrhythmia and is a heart condition that causes an irregula ...

PharmaPoint: Venous Thromboembolism - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Venous Thromboembolism - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • August 2016
  • by Global Data

PharmaPoint: Venous Thromboembolism - Global Drug Forecast and Market Analysis to 2025 Summary Venous thromboembolism (VTE) is a disease that includes a myriad of life-threatening disorders ranging from ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.